Free Trial

Day One Biopharmaceuticals (DAWN) SEC Filings & 10K Form

Day One Biopharmaceuticals logo
$6.80 +0.07 (+1.04%)
Closing price 07/3/2025 03:00 PM Eastern
Extended Trading
$6.80 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Day One Biopharmaceuticals SEC Filings

DateFilerForm TypeView
06/18/2025
6:41 PM
Day One Biopharmaceuticals (Issuer)
VASCONCELLES MICHAEL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2025
6:42 PM
Day One Biopharmaceuticals (Issuer)
VASCONCELLES MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
4:47 PM
Day One Biopharmaceuticals (Issuer)
Josey John A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
4:47 PM
Day One Biopharmaceuticals (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
4:49 PM
Day One Biopharmaceuticals (Issuer)
Nicholson Garry A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
4:50 PM
Day One Biopharmaceuticals (Issuer)
Garland J. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
4:51 PM
Day One Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
4:53 PM
Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
4:54 PM
Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:44 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:45 PM
Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:48 PM
Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:54 PM
Day One Biopharmaceuticals (Issuer)
Merendino Lauren (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
4:45 PM
BlackRock, Inc. (Filed by)
Day One Biopharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/11/2025
3:01 PM
Day One Biopharmaceuticals (Filer)
Form DEF 14A
04/11/2025
3:03 PM
Day One Biopharmaceuticals (Filer)
Form DEFA14A
04/11/2025
3:06 PM
Day One Biopharmaceuticals (Filer)
Form ARS
03/06/2025
4:02 PM
Day One Biopharmaceuticals (Filer)
Form 10-K/A
02/28/2025
6:50 PM
Day One Biopharmaceuticals (Issuer)
Merendino Lauren (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/21/2025
5:05 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
5:08 PM
Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
5:10 PM
Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
5:02 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
5:04 PM
Day One Biopharmaceuticals (Subject)
York Charles N II (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
5:07 PM
Day One Biopharmaceuticals (Subject)
Dubow Adam (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
5:31 PM
Day One Biopharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/12/2025
8:28 AM
Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
01/31/2025
3:33 PM
Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:36 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:38 PM
Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:07 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
3:21 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
3:22 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:15 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
8:24 AM
Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/07/2024
8:12 AM
Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G
11/04/2024
4:24 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:48 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:53 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:59 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
5:07 PM
Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Is Elon's empire crumbling? (Ad)

The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Click here to see the Tesla shock that could blindside everyone.
08/19/2024
5:12 PM
Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:17 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
4:23 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
6:35 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
6:04 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
5:04 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
3:32 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/05/2024
5:11 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DAWN) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners